146 related articles for article (PubMed ID: 14554218)
1. Use of volumetric computerized tomography as a primary outcome measure to evaluate drug efficacy in the prevention of peri-prosthetic osteolysis: a 1-year clinical pilot of etanercept vs. placebo.
Schwarz EM; Campbell D; Totterman S; Boyd A; O'Keefe RJ; Looney RJ
J Orthop Res; 2003 Nov; 21(6):1049-55. PubMed ID: 14554218
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of etanercept for wear debris-induced osteolysis.
Childs LM; Goater JJ; O'Keefe RJ; Schwarz EM
J Bone Miner Res; 2001 Feb; 16(2):338-47. PubMed ID: 11204434
[TBL] [Abstract][Full Text] [Related]
3. Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
Tyring S; Gordon KB; Poulin Y; Langley RG; Gottlieb AB; Dunn M; Jahreis A
Arch Dermatol; 2007 Jun; 143(6):719-26. PubMed ID: 17576937
[TBL] [Abstract][Full Text] [Related]
4. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
Temple AR; Benson GD; Zinsenheim JR; Schweinle JE
Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643
[TBL] [Abstract][Full Text] [Related]
5. [Effect of alendronate on periprosthetic bone loss after cemented primary total hip arthroplasty: a prospective randomized study].
Nehme A; Maalouf G; Tricoire JL; Giordano G; Chiron P; Puget J
Rev Chir Orthop Reparatrice Appar Mot; 2003 Nov; 89(7):593-8. PubMed ID: 14699304
[TBL] [Abstract][Full Text] [Related]
6. Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial.
Sankar V; Brennan MT; Kok MR; Leakan RA; Smith JA; Manny J; Baum BJ; Pillemer SR
Arthritis Rheum; 2004 Jul; 50(7):2240-5. PubMed ID: 15248223
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of etanercept in an integrated multistudy database of patients with psoriasis.
Gordon K; Korman N; Frankel E; Wang H; Jahreis A; Zitnik R; Chang T
J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S101-11. PubMed ID: 16488320
[TBL] [Abstract][Full Text] [Related]
8. Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial.
Krueger GG; Langley RG; Finlay AY; Griffiths CE; Woolley JM; Lalla D; Jahreis A
Br J Dermatol; 2005 Dec; 153(6):1192-9. PubMed ID: 16307657
[TBL] [Abstract][Full Text] [Related]
9. Unsatisfactory results with the cementless Omnifit acetabular component due to polyethylene and severe osteolysis.
Nieuwenhuis JJ; Malefijt Jde W; Hendriks JC; Gosens T; Bonnet M
Acta Orthop Belg; 2005 Jun; 71(3):294-302. PubMed ID: 16035702
[TBL] [Abstract][Full Text] [Related]
10. Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
Keystone EC; Schiff MH; Kremer JM; Kafka S; Lovy M; DeVries T; Burge DJ
Arthritis Rheum; 2004 Feb; 50(2):353-63. PubMed ID: 14872476
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
12. [Expression of Caspase-3 and apoptosis in interface membranes of aseptically-loose total hip replacement].
Cheng T; Dai M; Wei J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Aug; 21(8):810-3. PubMed ID: 17882873
[TBL] [Abstract][Full Text] [Related]
13. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
Kivitz A; Ma C; Ahdieh H; Galer BS
Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of etanercept as monotherapy for psoriasis.
Gottlieb AB; Matheson RT; Lowe N; Krueger GG; Kang S; Goffe BS; Gaspari AA; Ling M; Weinstein GD; Nayak A; Gordon KB; Zitnik R
Arch Dermatol; 2003 Dec; 139(12):1627-32; discussion 1632. PubMed ID: 14676082
[TBL] [Abstract][Full Text] [Related]
15. Uncemented total hip arthroplasty for primary osteoarthritis in young patients: a mid-to long-term follow-up study from the Finnish Arthroplasty Register.
Eskelinen A; Remes V; Helenius I; Pulkkinen P; Nevalainen J; Paavolainen P
Acta Orthop; 2006 Feb; 77(1):57-70. PubMed ID: 16534703
[TBL] [Abstract][Full Text] [Related]
16. Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis.
Schwarz EM; Benz EB; Lu AP; Goater JJ; Mollano AV; Rosier RN; Puzas JE; Okeefe RJ
J Orthop Res; 2000 Nov; 18(6):849-55. PubMed ID: 11192243
[TBL] [Abstract][Full Text] [Related]
17. A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects.
Martínez-Taboada VM; Rodríguez-Valverde V; Carreño L; López-Longo J; Figueroa M; Belzunegui J; Mola EM; Bonilla G
Ann Rheum Dis; 2008 May; 67(5):625-30. PubMed ID: 18086726
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 2 doses of etanercept (50 vs 100 mg) in active rheumatoid arthritis: a randomized double blind study.
Johnsen AK; Schiff MH; Mease PJ; Moreland LW; Maier AL; Coblyn JS; Helfgott SM; Leff JA; Weinblatt ME
J Rheumatol; 2006 Apr; 33(4):659-64. PubMed ID: 16482646
[TBL] [Abstract][Full Text] [Related]
19. Assessment of health-related quality of life after surgical treatment of focal symptomatic spinal stenosis compared with osteoarthritis of the hip or knee.
Rampersaud YR; Ravi B; Lewis SJ; Stas V; Barron R; Davey R; Mahomed N
Spine J; 2008; 8(2):296-304. PubMed ID: 17669690
[TBL] [Abstract][Full Text] [Related]
20. Role of hydroxyapatite coating in resisting wear particle migration and osteolysis around acetabular components.
Coathup MJ; Blackburn J; Goodship AE; Cunningham JL; Smith T; Blunn GW
Biomaterials; 2005 Jul; 26(19):4161-9. PubMed ID: 15664643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
